 preliminari result invas bladder cancer transurethr resect neoadjuv chemotherapi pelvic irradi cisplatin chemotherapi preliminari data feasibl pilot studi signific subgroup patient muscle-invad bladder tumor local cure bladder preserv patient possibl develop distant metastas transurethr surgic resect neoadjuv methotrex cisplatin vinblastin chemotherapi addit cours cisplatin cgi tumor cystoscop re-evalu biopsi cytolog cisplatin partial irradi cgi immedi cystectomi tumor consolid radiotherapi boost total cgi addit cours cisplatin consecut patient plan treatment median followup month month enter patient aliv cystectomi distant metastas patient protocol chemotherapi dose reduct stomat bone marrow depress renal dysfunct seriou complic treatment-rel sepsi death signific renal dysfunct patient underw immedi radic cystectomi posit biopsi and/or cytolog result full chemotherapi radiotherapi signific bladder bowel injuri patient bladder recurr full chemotherapi radiotherapi number date patient persist recurr bladder tumor invas tumor cystectomi situ intraves therapi true success select bladder-preserv treatment year followup confid treatment bladder cancer feasibl studi practic signific proport patient sustain complet respons over-al surviv rate year efficaci methotrex cisplatin vinblastin chemotherapi prevent occult distant micrometastas rate success bladder preserv may random phase trial neoadjuv methotrex cisplatin vinblastin chemotherapi